相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。IFNγ and TNFα mediate CCL22/MDC production in alveolar macrophages after hemorrhage and resuscitation
Nadine Beckmann et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2020)
Natural Compounds with Potential to Modulate Cancer Therapies and Self-Reactive Immune Cells
Rhiane Moody et al.
CANCERS (2020)
Curcumin: a potent agent to reverse epithelial-to-mesenchymal transition
Afsane Bahrami et al.
CELLULAR ONCOLOGY (2019)
A marine-sourced fucoidan solution inhibits Toll-like-receptor-3-induced cytokine release by human bronchial epithelial cells
M. Dutot et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Natural Plants Compounds as Modulators of Epithelial-to-Mesenchymal Transition
Lorena Avila-Carrasco et al.
FRONTIERS IN PHARMACOLOGY (2019)
Prognostic Significance of Tumor-Associated Macrophage Content in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
Ayan Tyagi Kumar et al.
FRONTIERS IN ONCOLOGY (2019)
A High-Content Screening Approach to Identify MicroRNAs Against Head and Neck Cancer Cell Survival and EMT in an Inflammatory Microenvironment
Bruno Sangiorgi et al.
FRONTIERS IN ONCOLOGY (2019)
Caffeic acid phenethyl ester exerts apoptotic and oxidative stress on human multiple myeloma cells
Elizabeth Hernandez Marin et al.
INVESTIGATIONAL NEW DRUGS (2019)
Impact of curcumin on toll-like receptors
Motahare Boozari et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Macrophages in the microenvironment of head and neck cancer: potential targets for cancer therapy
Diane Evrard et al.
ORAL ONCOLOGY (2019)
Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment
Marie-Nicole Theodoraki et al.
CANCER RESEARCH (2018)
Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review
Vahid Soleimani et al.
PHYTOTHERAPY RESEARCH (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Exosomes in HNSCC plasma as surrogate markers of tumour progression and immune competence
M. -N. Theodoraki et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)
Head and Neck Carcinoma Immunotherapy: Facts and Hopes
Theresa L. Whiteside
CLINICAL CANCER RESEARCH (2018)
Curcumin, an active component of turmeric (Curcuma longa), and its effects on health
Betul Kocaadam et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2017)
EMT: Present and future in clinical oncology
Patricia G. Santamaria et al.
MOLECULAR ONCOLOGY (2017)
Fibroblasts and macrophages: Key players in the head and neck cancer microenvironment
Kusumawadee Utispan et al.
JOURNAL OF ORAL BIOSCIENCES (2017)
Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy
Kristina Iribarren et al.
ONCOIMMUNOLOGY (2016)
Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells
M. Ricciardi et al.
BRITISH JOURNAL OF CANCER (2015)
Immunology and Immunotherapy of Head and Neck Cancer
Robert L. Ferris
JOURNAL OF CLINICAL ONCOLOGY (2015)
Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer
Jens U. Marquardt et al.
JOURNAL OF HEPATOLOGY (2015)
Poly(I:C) as cancer vaccine adjuvant: Knocking on the door of medical breakthroughs
Rachid Ammi et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration
Timothy J. Zumwalt et al.
ONCOTARGET (2015)
cu Combination of IFNα and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attraction
Ravikumar Muthuswamy et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Discordant Biological and Toxicological Species Responses to TLR3 Activation
William M. Mitchell et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Curcumin, a component of golden spice: From bedside to bench and back
Sandeo Prasad et al.
BIOTECHNOLOGY ADVANCES (2014)
Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522
K. Kian Ang et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Molecular Pathways: Toll-like Receptors in the Tumor Microenvironment-Poor Prognosis or New Therapeutic Opportunity
Lisa A. Ridnour et al.
CLINICAL CANCER RESEARCH (2013)
Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): Anti-inflammatory and anti-cancer properties
Anlys Olivera et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Separation of human CD4+CD39+ T cells by magnetic beads reveals two phenotypically and functionally different subsets
Patrick J. Schuler et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Tumor Microenvironment and Progression
Harold F. Dvorak et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Established and novel NF-κB inhibitors lead to downregulation of TLR3 and the proliferation and cytokine secretion in HNSCC
Christian Meyer et al.
ORAL ONCOLOGY (2011)
TNF-α/NF-κB/Snail pathway in cancer cell migration and invasion
Y. Wu et al.
BRITISH JOURNAL OF CANCER (2010)
Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer
Mathilde Bayet-Robert et al.
CANCER BIOLOGY & THERAPY (2010)
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian et al.
CELL (2010)
Biomolecular Network Reconstruction Identifies T-Cell Homing Factors Associated With Survival in Colorectal Cancer
Bernhard Mlecnik et al.
GASTROENTEROLOGY (2010)
Effect of Curcumin on Nuclear Factor kappa B Signaling Pathways in Human Chronic Myelogenous K562 Leukemia Cells
Simone Reuter et al.
NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS (2009)
Ampligen: A potential toll-like 3 receptor adjuvant for immunotherapy of cancer
B. Jasani et al.
VACCINE (2009)
Phase II trial of curcumin in patients with advanced pancreatic cancer
Navneet Dhillon et al.
CLINICAL CANCER RESEARCH (2008)
Regulatory T cells: What role do they play in antitumor immunity in patients with head and neck cancer?
Osama Alhamarneh et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2008)
Cytotoxicity of NF-κB inhibitors Bay 11-7085 and caffeic acid phenethyl ester to Ramos and other human B-lymphoma cell lines
Nir Berger et al.
EXPERIMENTAL HEMATOLOGY (2007)
Toll-like receptors and type I interferons
Satoshi Uematsu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Nuclear factor-κ13 in development, prevention, and therapy of cancer
Carter Van Waes
CLINICAL CANCER RESEARCH (2007)
Relationships between regulatory T cells and CD8+effector populations in patients with squamous cell carcinoma of the head and neck
Kazuaki Chikamatsu et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2007)
Cancer despite immunosurveillance: immunoselection and immunosubversion
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Innate immune recognition of viral infection
T Kawai et al.
NATURE IMMUNOLOGY (2006)
NFκB:: Linking inflammation and immunity to cancer development and progression
M Karin et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Interferon regulatory factor 1 is an essential and direct transcriptional activator for interferon γ-induced RANTES/CC15 expression in macrophages
JG Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-κB and IκB kinase pathway to regulate the release of proinflammatory cytokines from human adipose tissue and skeletal muscle in vitro
M Lappas et al.
ENDOCRINOLOGY (2005)
Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells
T Alvaro et al.
CLINICAL CANCER RESEARCH (2005)
Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-κB signaling
S Aggarwal et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck
JS Cooper et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
分享论文
